The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women With Bone Loss

NCT00460057 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
63
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Eulji University Hospital